These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16356815)

  • 1. The radiological appearances of thalassaemia.
    Tyler PA; Madani G; Chaudhuri R; Wilson LF; Dick EA
    Clin Radiol; 2006 Jan; 61(1):40-52. PubMed ID: 16356815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: predominance of osteoporosis and desferrioxamine-induced bone dysplasia.
    Chan YL; Pang LM; Chik KW; Cheng JC; Li CK
    Pediatr Radiol; 2002 Jul; 32(7):492-7. PubMed ID: 12107582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of radiologic skeletal changes in thalassemia.
    Bedair EM; Helmy AN; Yakout K; Soliman AT
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():123-6. PubMed ID: 19337165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desferrioxamine-induced long bone changes in thalassaemic patients - radiographic features, prevalence and relations with growth.
    Chan YL; Li CK; Pang LM; Chik KW
    Clin Radiol; 2000 Aug; 55(8):610-4. PubMed ID: 10964732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evolutionary effects of therapy on the skeletal lesions in beta-thalassemia].
    Orzincolo C; Castaldi G; Bariani L; Scutellari PN
    Radiol Med; 1994 Apr; 87(4):381-8. PubMed ID: 8190918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of skeletal dysplasia in thalassaemia major.
    Naselli A; Vignolo M; Di Battista E; Garzia P; Forni GL; Traverso T; Aicardi G
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():817-25. PubMed ID: 10091152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A; Kusuwan T; Limviriyakul S; Atipas S; Pooliam J; Sangpraypan T; Tanphaichitr VS; Viprakasit V
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approach to iron chelation in children.
    Aydinok Y; Kattamis A; Viprakasit V
    Br J Haematol; 2014 Jun; 165(6):745-55. PubMed ID: 24646011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone secretion and bone histomorphometric study in thalassaemic patients with acquired skeletal dysplasia secondary to desferrioxamine.
    De Sanctis V; Stea S; Savarino L; Scialpi V; Traina GC; Chiarelli GM; Sprocati M; Govoni R; Pezzoli D; Gamberini R; Rigolin F
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():827-33. PubMed ID: 10091153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
    Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
    Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five Years of Deferasirox Therapy for Cardiac Iron in β-Thalassemia Major.
    Vlachaki E; Agapidou A; Spanos G; Klonizakis P; Vetsiou E; Mavroudi M; Boura P
    Hemoglobin; 2015; 39(5):299-304. PubMed ID: 26177199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anomalies of the masticatory apparatus in beta-thalassemia. The present status after transfusion and iron-chelating therapy].
    Scutellari PN; Orzincolo C; Andraghetti D; Gamberini MR
    Radiol Med; 1994 Apr; 87(4):389-96. PubMed ID: 8190919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short stature and body proportion in thalassaemia.
    Caruso-Nicoletti M; De Sanctis V; Capra M; Cardinale G; Cuccia L; Di Gregorio F; Filosa A; Galati MC; Lauriola A; Malizia R; Mangiagli A; Massolo F; Mastrangelo C; Meo A; Messina MF; Ponzi G; Raiola G; Ruggiero L; Tamborino G; Saviano A
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():811-6. PubMed ID: 10091151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of long-term iron chelation therapy on growth and endocrine functions in thalassaemia.
    De Sanctis V; Roos M; Gasser T; Fortini M; Raiola G; Galati MC;
    J Pediatr Endocrinol Metab; 2006 Apr; 19(4):471-80. PubMed ID: 16759032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
    Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
    Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of deferoxamine-induced bone dysplasia in an 8-year-old female with thalassemia major.
    Miller TT; Caldwell G; Kaye JJ; Arkin S; Burke S; Brill PW
    Pediatr Radiol; 1993; 23(7):523-4. PubMed ID: 8309753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major.
    Wu KH; Chang JS; Tsai CH; Peng CT
    Ann Hematol; 2004 Jul; 83(7):471-3. PubMed ID: 14658011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deferoxamine-induced bone dysplasia in the distal femur and patella of pediatric patients and young adults: MR imaging appearance.
    Chan Y; Li C; Chu WC; Pang L; Cheng JC; Chik KW
    AJR Am J Roentgenol; 2000 Dec; 175(6):1561-6. PubMed ID: 11090375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe thalassaemia intermedia with multiple fractures: role of transfusion therapy.
    Ahmad SQ; Iqbal M; Wahla MS; Tarrar AM
    J Pak Med Assoc; 2011 Nov; 61(11):1137-9. PubMed ID: 22125999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.